Article

Schwind & Zeimer join forces

Schwind and Zeimer announced today that they will cooperate to supply an integrated all-laser LASIK solution.

Schwind and Zeimer announced today that they will cooperate to supply an integrated all-laser LASIK solution.

The partnership will focus on joint marketing of Schwind's Amaris excimer laser and Zeimer's Femto LDV femtosecond surgical laser, offering precision, optimized workflow and shortened procedure times.

The partners will present the package solution through their existing distribution networks. According to Schwind President and CEO, Rolf Schwind, the two companies already share distributors in some markets. "It will be very easy to work together, " he said.

Schwind says the companies have come together to answer demand for a package solution. "The refractive community is small and we have known Zeimer for many years. We talk all the time at congresses like the annual ESCRS meeting; we have knowledge about excimer lasers, Zeimer has knowledge about femtosecond lasers. If you put those two products together in a package together you can present a stronger offering. "

Schwind sees the similarities in the two businesses as a strong foundation for the alliance. "Agreement between a multinational and a medium sized family business will be difficult. The philosophy of multinational companies and family companies are different. We are not interested in our stock market price, but sometimes bigger companies are more interested in this than in their customers. "

The Schwind-Ziemer marketing alliance is non-exclusive and both companies will continue to market and sell their products independently.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.